Table 5. Variations of indices in ALT <40 and ALT >40 group after Lira treatment for 12 weeks.

Term	ALT <40 (n=29)	ALT >40 (n=23)	t	P
Age (year)	57.3 ± 5.8	60.1 ± 4.9	−1.85	0.07
Gender ratio (male/female)	16/14	15/8	-	0.533
Weight (kg)	75.33 ± 5.66	78.92 ± 4.56	−1.78	0.08
BMI (kg/m2)	24.93 ± 1.02	27.05 ± 0.862	−7.97	0.000
WHR	0.93 ± 0.04	0.98 ± 0.071	−2.19	0.033
TC (mmol/l)	4.72 ± 0.63	5.08 ± 0.461	−2.30	0.026
TG (mmol/l)	1.78 ± 0.21	1.93 ± 0.37	−1.84	0.071
LDL (mmol/l)	2.39 ± 0.29	2.55 ± 0.271	−2.04	0.047
HDL (mmol/l)	1.02 ± 0.24	1.09 ± 0.21	−1.10	0.275
FPG (mmol/l)	6.75 ± 0.33	7.56 ± 0.342	−8.67	0.000
2hPG (mmol/l)	9.75 ± 1.79	11.03 ± 2.521	−2.41	0.037
HbA1C (%)	7.14 ± 0.45	7.35 ± 0.57	−1.49	0.144
HOMA-IR	2.29 ± 0.35	2.69 ± 0.382	−3.94	0.000
APN (mg/l)	9.48 ± 2.15	10.87 ± 2.041	−2.37	0.021
CRP (mg/l)	2.07 ± 0.19	2.32 ± 0.222	−4.39	0.000

Compared with the ALT <40 group.

¹P<0.05 .

²P<0.01 (unpaired t test).

³Chi-square test.